Medtronic plc is 46.9x more valuable than Axogen, Inc. by market capitalization ($103.03 B vs $2.20 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AXGN | MDT |
|---|---|---|
| Market cap | $2.20 B | $103.03 B |
| US-listed rank | #2035 | #146 |
| Revenue (latest FY) | $225.21M | $33.54B |
| Net income (latest FY) | -$15.70M | $4.66B |
| Net margin | -7.0% | 13.9% |
| P/E (trailing FY) | - | 22.1 |
| SEC filings | 1,334 | 998 |
Medtronic plc is 46.9x more valuable than Axogen, Inc. by market capitalization ($103.03 B vs $2.20 B).
In their latest fiscal years, Axogen, Inc. reported $225.21M in revenue while Medtronic plc reported $33.54B.
Full pages: Axogen, Inc. and Medtronic plc, or browse the full rankings.